HOME › DRUGS › LENADOGENE NOLPARVOVEC
ACTIVE SUBSTANCE / INN

LENADOGENE NOLPARVOVEC

Brand name(s): Lumevoq
EMA LISTED
APPLICATION WITHDRAWN
Optic Atrophy, Hereditary, Leber
ACTIVE SUBSTANCE
Lenadogene Nolparvovec
REGULATORS
EMA
SPONSORS / MAH
GenSight Biologics S.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LumevoqGenSight Biologics S.A.Application withdrawnOptic Atrophy, Hereditary, Leber

FULL INTELLIGENCE ON LENADOGENE NOLPARVOVEC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →